Peritoneal Dialysis Market Report by Treatment Type (Continuous Ambulatory Peritoneal Dialysis, Automated Peritoneal Dialysis ), Product, End User, and Region 2024-2032
세계 복막 투석 시장 규모는 2023년 173억 달러에 달했습니다. 향후 IMARC Group은 2024-2032년 4.38%의 연평균 성장률(CAGR)을 보이며 2032년까지 257억 달러에 달할 것으로 예상하고 있습니다.
복막 투석(PD)은 신부전 치료의 일종으로, 수술로 복강 내 또는 복부에 부드러운 플라스틱 튜브 또는 카테터를 삽입하는 방법입니다. 카테터가 삽입되면 무균 세정액이 덕트를 통해 주입되어 체내 혈액을 여과하고 노폐물을 제거합니다. 일정 시간이 지나면 액체와 여과된 불필요한 성분은 복부 밖으로 배출되어 폐기됩니다. 복막 투석은 지속적 외래 복막 투석과 지속적 순환식 복막 투석(CCPD)으로 구분됩니다. 이러한 방법은 치료의 유연성을 제공하고 투석 센터 방문의 필요성을 줄이며 더 나은 임상 결과를 가져오고 결과적으로 더 적은 약물 복용량과 더 적은 식사 제한을 가져옵니다. 또한 집에서 할 수 있고 바늘을 사용하지 않기 때문에 병원과 의료 센터에서 신부전 치료에 사용되고 있습니다.
복막 투석 시장 동향 :
고혈압, 당뇨병, 말기 신부전증(ESRD)의 유병률 증가, 신장 기증자 부족, 신장 이식에 따른 위험에 대한 소비자 인식이 높아짐에 따라 신장 이식 시장의 성장이 크게 촉진되고 있습니다. 또한, 특히 코로나19 팬데믹 상황에서 재택 투석 치료의 필요성이 증가하고 있는 것도 성장의 원동력이 되고 있습니다. 또한, 자동 복막 투석(APD)과 같이 환자의 신장 대체 요법 및 야간 다중 교환을 위한 다양한 기술의 출현이 시장 성장에 기여하고 있습니다. 이러한 첨단 제품은 복막염과 탈장 발생률을 낮추고, 특히 만성콩팥병(CKD)을 앓고 있는 노년층에게 더 나은 미량 용질 제거를 제공하는 데 도움을 주고 있습니다. 또한, 비용 효율적인 가격으로 환자의 이동성을 높이고 증상의 변동성을 줄이기 위해 의료진이 혈액 투석보다 PD를 선호하고 있는 것도 시장 성장을 가속하고 있습니다. 이 외에도 정부의 연구개발(R&D)에 대한 광범위한 투자, 개선된 상환 정책, 제품 다양화 등이 시장 성장에 긍정적인 영향을 미치고 있습니다.
본 보고서에서 다룬 주요 질문들
- 세계 복막 투석 시장은 지금까지 어떻게 성장해왔고, 앞으로 어떻게 성장할 것인가?
- 코로나19는 세계 복막 투석 시장에 어떤 영향을 미쳤을까?
- 주요 지역 시장은?
- 치료 유형별 시장 현황은?
- 제품별 시장 분석은?
- 최종사용자별 시장 분석은?
- 산업 가치사슬의 다양한 단계는?
- 업계의 주요 촉진요인과 과제는?
- 세계 복막 투석 시장 구조와 주요 진출 기업은?
- 업계의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 복막 투석 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 치료 유형별
- 지속 휴대형 복막 투석(CAPD)
- 자동 복막 투석(APD)
제7장 시장 분석 : 제품별
- 복막 투석액
- 복막 투석 장비
- 복막 투석 세트
- 복막 투석 카테터
- 기타
제8장 시장 분석 : 최종사용자별
제9장 시장 분석 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter의 Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁 정도
- 신규 진출업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 개요
- Amecath
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medical Components Inc.
- Medionics International Inc.
- Medtronic plc
- Merit Medical Systems Inc.
- Mitra Industries Pvt. Ltd.
- Newsol Technologies Inc.
- Nipro Canada(Nipro Medical Corporation)
- Poly Medicure Limited
- Terumo Corporation
- Utah Medical Products Inc.
LSH
The global peritoneal dialysis market size reached US$ 17.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.38% during 2024-2032.
Peritoneal dialysis (PD) represents a type of kidney failure treatment procedure wherein a soft plastic tube or catheter is placed in the abdominal lining or belly through surgery. Once it is positioned, a sterile cleansing fluid is transmitted by the duct that helps filter the blood inside an individual's body by removing waste products. After a period of time, the liquid and filtered unwanted components flow out of the abdomen and are discarded. PD is differentiated into continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis (CCPD). These approaches offer treatment flexibility, reduce the need to visit dialysis centers, and provide better clinical outcomes, resulting in lesser medications and fewer food restrictions. Apart from this, it can be carried out at home and is needle-free; thus, PD is used by hospitals and healthcare centers to treat kidney failures.
Peritoneal Dialysis Market Trends:
The increasing prevalence of hypertension, diabetes, and end-stage renal disease (ESRD), the rising shortages of kidney donors, and the emerging awareness amongst consumers regarding the risks associated with kidney transplants are majorly driving the market growth. Moreover, the growing need for home dialysis treatments, especially during the COVID-19 pandemic, is acting as another growth-inducing factor. Furthermore, the advent of various technologies, such as automated peritoneal dialysis (APD), to perform renal replacement therapy for patients and multiple exchanges at night is contributing to the market growth. Such advanced products aid in lowering the incidences of peritonitis and hernias and offer better small solute clearances, especially to the geriatric population facing chronic kidney disease (CKD). Additionally, the shifting inclination of health practitioners toward PD over haemodialysis as it ensures greater patient mobility at cost-effective prices while creating fewer symptom fluctuations is propelling the market growth. Apart from this, extensive investments in research and development activities (R&D) by governments, improving reimbursement policies, and the ongoing product diversification are positively stimulating the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global peritoneal dialysis market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on treatment type, product and end user.
Breakup by Treatment Type:
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Breakup by Product:
Peritoneal Dialysis Solution
Peritoneal Dialysis Devices
Peritoneal Dialysis Sets
Peritoneal Dialysis Catheters
Others
Breakup by End User:
Home-based Dialysis
Dialysis Centers and Hospital-based Dialysis
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amecath, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medical Components Inc., Medionics International Inc., Medtronic plc, Merit Medical Systems Inc., Mitra Industries Pvt. Ltd., Newsol Technologies Inc., Nipro Canada (Nipro Medical Corporation), Poly Medicure Limited, Terumo Corporation and Utah Medical Products Inc.
Key Questions Answered in This Report:
- How has the global peritoneal dialysis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global peritoneal dialysis market?
- What are the key regional markets?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global peritoneal dialysis market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Peritoneal Dialysis Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Treatment Type
- 6.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Automated Peritoneal Dialysis (APD)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Product
- 7.1 Peritoneal Dialysis Solution
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Peritoneal Dialysis Devices
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Peritoneal Dialysis Sets
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Peritoneal Dialysis Catheters
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End User
- 8.1 Home-based Dialysis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Dialysis Centers and Hospital-based Dialysis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Amecath
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Baxter International Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Fresenius Medical Care AG & Co. KGaA
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Medical Components Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Medionics International Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Medtronic plc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Merit Medical Systems Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Mitra Industries Pvt. Ltd.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Newsol Technologies Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Nipro Canada (Nipro Medical Corporation)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Poly Medicure Limited
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Terumo Corporation
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Utah Medical Products Inc.
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
